Cargando…
Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183773/ https://www.ncbi.nlm.nih.gov/pubmed/25192414 http://dx.doi.org/10.1038/bcj.2014.64 |
| _version_ | 1782337746230050816 |
|---|---|
| author | Zugmaier, G Topp, M S Alekar, S Viardot, A Horst, H-A Neumann, S Stelljes, M Bargou, R C Goebeler, M Wessiepe, D Degenhard, E Gökbuget, N Klinger, M |
| author_facet | Zugmaier, G Topp, M S Alekar, S Viardot, A Horst, H-A Neumann, S Stelljes, M Bargou, R C Goebeler, M Wessiepe, D Degenhard, E Gökbuget, N Klinger, M |
| author_sort | Zugmaier, G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4183773 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41837732014-10-03 Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia Zugmaier, G Topp, M S Alekar, S Viardot, A Horst, H-A Neumann, S Stelljes, M Bargou, R C Goebeler, M Wessiepe, D Degenhard, E Gökbuget, N Klinger, M Blood Cancer J Letter to the Editor Nature Publishing Group 2014-09 2014-09-05 /pmc/articles/PMC4183773/ /pubmed/25192414 http://dx.doi.org/10.1038/bcj.2014.64 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| spellingShingle | Letter to the Editor Zugmaier, G Topp, M S Alekar, S Viardot, A Horst, H-A Neumann, S Stelljes, M Bargou, R C Goebeler, M Wessiepe, D Degenhard, E Gökbuget, N Klinger, M Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia |
| title | Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia |
| title_full | Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia |
| title_fullStr | Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia |
| title_full_unstemmed | Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia |
| title_short | Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia |
| title_sort | long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive b-precursor acute lymphoblastic leukemia |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183773/ https://www.ncbi.nlm.nih.gov/pubmed/25192414 http://dx.doi.org/10.1038/bcj.2014.64 |
| work_keys_str_mv | AT zugmaierg longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia AT toppms longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia AT alekars longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia AT viardota longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia AT horstha longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia AT neumanns longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia AT stelljesm longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia AT bargourc longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia AT goebelerm longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia AT wessieped longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia AT degenharde longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia AT gokbugetn longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia AT klingerm longtermfollowupofserumimmunoglobulinlevelsinblinatumomabtreatedpatientswithminimalresidualdiseasepositivebprecursoracutelymphoblasticleukemia |